| Michael Lloyd Dolan, RN | |
|
18511 Highlander Medics St, Fort Bliss, Tx 79918, Apo, AA 79918 | |
| (915) 742-2121 | |
| Not Available |
| Full Name | Michael Lloyd Dolan |
|---|---|
| Gender | Male |
| Speciality | Registered Nurse |
| Location | 18511 Highlander Medics St, Fort Bliss, Tx 79918, Apo, Armed Forces Americas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831878040 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN9438736 (Florida) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Lloyd Dolan, RN 18511 Highlander Medics St, Fort Bliss, Tx 79918, Apo, AA 79918 Ph: () - | Michael Lloyd Dolan, RN 18511 Highlander Medics St, Fort Bliss, Tx 79918, Apo, AA 79918 Ph: (915) 742-2121 |
News Archive
The CDC has announced new guidelines to reduce the risk of catheter-associated infections in the United States. The guidelines now designate treatment with chlorhexidine gluconate-impregnated sponge as a category 1B recommendation exclusively based on evidence related to BIOPATCH® Protective Disk with CHG.
InspireMD, Ltd. announced today the next generation MGuard stent, MGuard Prime(R), a net protective Cobalt Chromium stent system. MGuard Prime(R) offers an advanced patented Cobalt Chromium design, superior flexibility and excellent deliverability on top of the established benefits of the MGuard MicroNet(R) technology.
NanoViricides, Inc. (the "Company") reports that its optimized injectable FluCide® drug candidate was found to be well tolerated in a non-GLP small animal safety/toxicology study. This study is an important step in the drug development pathway for FluCide.
The widespread use of a simplified clinical tool to estimate future coronary risk could lead to the classification of millions of Americans into different risk groups than when using the original, "gold-standard" tool. Millions of patients may have been misclassified into higher-risk groups and therefore potentially over-treated, while others may have ended up in lower-risk groups and therefore potentially under-treated for heart disease. The study-, led by William Gordon from Weill Cornell Medical College in the US and colleagues, is published in the Journal of General Internal Medicine-, published by Springer.
Illumina, Inc. today announced its next generation of iSelect custom genotyping products that allow researchers to design custom arrays containing from 3,000 up to 1,000,000 markers, with the flexibility to add supplemental content to their array designs.
› Verified 8 days ago
Leona Marie Walker, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Bldg. 650 Huebner Road, Fort Riley, 66442, Apo, AA 66442 Phone: 785-240-7115 | |
Miss Emma Sombo Banya, CRNA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Psc 3 General Delivery, 694 A Street, Travis Airforce Base, Apo, AA 94535 Phone: 707-372-2500 | |
Chelsi Yuko Hennessey, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2240 Winrow Ave, Uas Meddac, Rwbahc, Apo, AA 85613 Phone: 520-533-2490 | |
Laura Stogner, DNP STUDENT Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4301 Jones Bridge Road, Apo, AA 20814 Phone: 301-295-9004 | |
Mrs. Mary Elizabeth Hudson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1300 Psc, Apo, AA 34042 Phone: 423-355-9495 | |
Mr. Junsung Cho, NP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Brian D. Allgood Army Community Hospital (bdaach) Unit, Unit #15245; Bldg 3031 Apo, Ap 96271, Apo, AA 96271 Phone: 726-206-6169 |